Indiana is a biomanufacturing juggernaut

Indiana is not just an academic research corridor. It is a biomanufacturing juggernaut.

By Milad Alucozai
Milad Alucozai taking a selfie with three Indiana life sciences leaders at an outdoor table in the Bay Area

We got the band back together! Great having my fellow Hoosiers come out to the Bay Area. I have deep roots across Indiana, and I'm bullish on the state because it punches far above its weight in life sciences.

  • Vince Wong, CEO of BioCrossroads
  • Josh Rabuck, Chief Investment Officer at Indiana University Health
  • David Rosenberg, CEO of IU Launch Accelerator for Biosciences (IU LAB)

Here is what many routinely miss about the state:

Indiana is not just an academic research corridor. It is a biomanufacturing juggernaut.

Indiana surpassed California as the #1 exporter of life sciences products in the entire United States, with $27 billion in exports and nearly $100 billion in total economic activity.

Eli Lilly and Company is anchoring that momentum with historic commitments. Indiana has become the manufacturing epicenter powering global breakthroughs like GLP-1 therapies.

At the same time, organizations like the ARI (Applied Research Institute) are powering Heartland BioWorks, a federally designated EDA Tech Hub securing the nation's domestic biomanufacturing and talent pipeline.

Pair that with IU Health deploying capital as one of the country's largest healthcare systems and IU Labs commercializing university discoveries, and you have an end-to-end value chain.

The Midwest is not waiting for outside permission to build. It is already doing the heavy lifting for global medicine.

Incredible momentum for many years to come.

Thank you Brandon Noll for bringing us together!

Originally posted on LinkedIn.

Share

More from Pamir

All stories